Bright Minds Biosciences Net Income
| DRUG Stock | USD 75.97 2.89 3.95% |
As of the 7th of February, Bright Minds shows the Risk Adjusted Performance of 0.1275, mean deviation of 3.52, and Downside Deviation of 4.09. Bright Minds Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bright Minds Biosciences information ratio, as well as the relationship between the potential upside and kurtosis to decide if Bright Minds Biosciences is priced correctly, providing market reflects its regular price of 75.97 per share. Given that Bright Minds has jensen alpha of 0.5137, we suggest you to validate Bright Minds Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.
Bright Minds' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bright Minds' valuation are provided below:There are over one hundred nineteen available fundamental signals for Bright Minds Biosciences, which can be analyzed over time and compared to other ratios. Active traders should verify all of Bright Minds Biosciences prevailing fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The Bright Minds' current Market Cap is estimated to increase to about 548.5 M. The Bright Minds' current Enterprise Value is estimated to increase to about 470.3 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -13.5 M | -12.8 M | |
| Net Loss | -11 M | -10.5 M | |
| Net Loss | -11 M | -11.6 M | |
| Net Loss | (2.04) | (2.15) | |
| Net Income Per E B T | 0.91 | 0.80 |
Bright | Net Income | Build AI portfolio with Bright Stock |
The Net Income trend for Bright Minds Biosciences offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Bright Minds is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Bright Minds' Net Income Growth Pattern
Below is the plot of the Net Income of Bright Minds Biosciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Bright Minds Biosciences financial statement analysis. It represents the amount of money remaining after all of Bright Minds Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Bright Minds' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bright Minds' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (12.23 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Bright Net Income Regression Statistics
| Arithmetic Mean | (4,115,153) | |
| Coefficient Of Variation | (129.09) | |
| Mean Deviation | 4,688,639 | |
| Median | (236,151) | |
| Standard Deviation | 5,312,372 | |
| Sample Variance | 28.2T | |
| Range | 14.7M | |
| R-Value | (0.77) | |
| Mean Square Error | 12.1T | |
| R-Squared | 0.60 | |
| Significance | 0.0003 | |
| Slope | (812,447) | |
| Total Sum of Squares | 451.5T |
Bright Net Income History
Other Fundumenentals of Bright Minds Biosciences
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Bright Minds Net Income component correlations
Bright Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Bright Minds is extremely important. It helps to project a fair market value of Bright Stock properly, considering its historical fundamentals such as Net Income. Since Bright Minds' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bright Minds' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bright Minds' interrelated accounts and indicators.
Click cells to compare fundamentals
Can Biotechnology industry sustain growth momentum? Does Bright have expansion opportunities? Factors like these will boost the valuation of Bright Minds. Projected growth potential of Bright fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Bright Minds demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Bright Minds Biosciences's market price often diverges from its book value, the accounting figure shown on Bright's balance sheet. Smart investors calculate Bright Minds' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Bright Minds' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bright Minds' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bright Minds should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bright Minds 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bright Minds' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bright Minds.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Bright Minds on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Bright Minds Biosciences or generate 0.0% return on investment in Bright Minds over 90 days. Bright Minds is related to or competes with LB Pharmaceuticals, Design Therapeutics, Aura Biosciences, EnGene Holdings, DiaMedica Therapeutics, Altimmune, and Annexon. Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patie... More
Bright Minds Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bright Minds' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bright Minds Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.09 | |||
| Information Ratio | 0.129 | |||
| Maximum Drawdown | 22.73 | |||
| Value At Risk | (5.73) | |||
| Potential Upside | 9.03 |
Bright Minds Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bright Minds' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bright Minds' standard deviation. In reality, there are many statistical measures that can use Bright Minds historical prices to predict the future Bright Minds' volatility.| Risk Adjusted Performance | 0.1275 | |||
| Jensen Alpha | 0.5137 | |||
| Total Risk Alpha | 0.222 | |||
| Sortino Ratio | 0.149 | |||
| Treynor Ratio | 0.3122 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bright Minds' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bright Minds February 7, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1275 | |||
| Market Risk Adjusted Performance | 0.3222 | |||
| Mean Deviation | 3.52 | |||
| Semi Deviation | 3.68 | |||
| Downside Deviation | 4.09 | |||
| Coefficient Of Variation | 676.11 | |||
| Standard Deviation | 4.73 | |||
| Variance | 22.38 | |||
| Information Ratio | 0.129 | |||
| Jensen Alpha | 0.5137 | |||
| Total Risk Alpha | 0.222 | |||
| Sortino Ratio | 0.149 | |||
| Treynor Ratio | 0.3122 | |||
| Maximum Drawdown | 22.73 | |||
| Value At Risk | (5.73) | |||
| Potential Upside | 9.03 | |||
| Downside Variance | 16.77 | |||
| Semi Variance | 13.52 | |||
| Expected Short fall | (3.88) | |||
| Skewness | 0.6185 | |||
| Kurtosis | 1.13 |
Bright Minds Biosciences Backtested Returns
Bright Minds appears to be very steady, given 3 months investment horizon. Bright Minds Biosciences secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. By analyzing Bright Minds' technical indicators, you can evaluate if the expected return of 0.52% is justified by implied risk. Please makes use of Bright Minds' Mean Deviation of 3.52, risk adjusted performance of 0.1275, and Downside Deviation of 4.09 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bright Minds holds a performance score of 8. The firm shows a Beta (market volatility) of 2.21, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bright Minds will likely underperform. Please check Bright Minds' potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Bright Minds' price patterns will revert.
Auto-correlation | -0.37 |
Poor reverse predictability
Bright Minds Biosciences has poor reverse predictability. Overlapping area represents the amount of predictability between Bright Minds time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bright Minds Biosciences price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Bright Minds price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 34.04 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Bright Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Bright Minds Biosciences reported net income of (12.23 Million). This is 103.58% lower than that of the Biotechnology sector and 117.46% lower than that of the Health Care industry. The net income for all United States stocks is 102.14% higher than that of the company.
Bright Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bright Minds' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bright Minds could also be used in its relative valuation, which is a method of valuing Bright Minds by comparing valuation metrics of similar companies.Bright Minds is currently under evaluation in net income category among its peers.
Bright Minds Current Valuation Drivers
We derive many important indicators used in calculating different scores of Bright Minds from analyzing Bright Minds' financial statements. These drivers represent accounts that assess Bright Minds' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Bright Minds' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 81.1M | 21.0M | 6.3M | 580.4M | 522.4M | 548.5M | |
| Enterprise Value | 61.4M | 9.5M | 734.8K | 497.7M | 447.9M | 470.3M |
Bright Minds ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bright Minds' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bright Minds' managers, analysts, and investors.Environmental | Governance | Social |
Bright Minds Institutional Holders
Institutional Holdings refers to the ownership stake in Bright Minds that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Bright Minds' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bright Minds' value.| Shares | Schonfeld Strategic Advisors Llc | 2025-06-30 | 69 K | Ikarian Capital, Llc | 2025-06-30 | 65.4 K | Geode Capital Management, Llc | 2025-06-30 | 57.5 K | Walleye Trading Advisors, Llc | 2025-06-30 | 53.4 K | Longwood Capital Partners Llc | 2025-06-30 | 48.5 K | Vanguard Group Inc | 2025-06-30 | 32 K | Junked Platinum Investment Management Ltd | 2025-06-30 | 28.3 K | Northern Trust Corp | 2025-06-30 | 25.6 K | State Street Corp | 2025-06-30 | 24.7 K | Hhg Plc | 2025-06-30 | 1.1 M | Cormorant Asset Management, Llc | 2025-06-30 | 1.1 M |
Bright Fundamentals
| Return On Equity | -0.28 | ||||
| Return On Asset | -0.19 | ||||
| Current Valuation | 676.32 M | ||||
| Shares Outstanding | 9.73 M | ||||
| Shares Owned By Insiders | 11.46 % | ||||
| Shares Owned By Institutions | 63.59 % | ||||
| Number Of Shares Shorted | 564.28 K | ||||
| Price To Book | 12.30 X | ||||
| EBITDA | (8.7 M) | ||||
| Net Income | (12.23 M) | ||||
| Cash And Equivalents | 8.64 M | ||||
| Cash Per Share | 0.71 X | ||||
| Total Debt | 125.78 K | ||||
| Current Ratio | 22.88 X | ||||
| Book Value Per Share | 7.86 X | ||||
| Cash Flow From Operations | (6.24 M) | ||||
| Short Ratio | 2.02 X | ||||
| Earnings Per Share | (1.30) X | ||||
| Target Price | 153.72 | ||||
| Number Of Employees | 26 | ||||
| Beta | -0.49 | ||||
| Market Capitalization | 725.57 M | ||||
| Total Asset | 84.42 M | ||||
| Retained Earnings | (33.44 M) | ||||
| Working Capital | 81.97 M | ||||
| Net Asset | 84.42 M |
About Bright Minds Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bright Minds Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bright Minds using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bright Minds Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Can Biotechnology industry sustain growth momentum? Does Bright have expansion opportunities? Factors like these will boost the valuation of Bright Minds. Projected growth potential of Bright fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Bright Minds demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Bright Minds Biosciences's market price often diverges from its book value, the accounting figure shown on Bright's balance sheet. Smart investors calculate Bright Minds' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Bright Minds' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bright Minds' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bright Minds should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.